Rankings
▼
Calendar
RXRX Q2 2020 Earnings — Recursion Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RXRX
Recursion Pharmaceuticals, Inc.
$2B
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$19M
EPS (Diluted)
$-0.11
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$769,000
← FY 2020
All Quarters
Q3 2020 →
